Yuhan to develop cell therapy with adult stem cell technologies.

Published: 2005-10-24 06:55:00

Updated: 2005-10-24 06:55:00

Two companies, Yuhan, one of big Koean pharmaceutical companies in Korea, and R&L Bio, one of biotech companies having the most advanced bio pharmaceutical technology in Korea announced to sign a joint research agreement as of Oct. 19 for the cell therapy by the use of adult stem cell technologie...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK